Follow
Silvia Redondo García
Silvia Redondo García
GENyO
Verified email at genyo.es
Title
Cited by
Cited by
Year
ADAMTS1 protease is required for a balanced immune cell repertoire and tumour inflammatory response
FJ Rodríguez-Baena, S Redondo-García, C Peris-Torres, ...
Scientific reports 8 (1), 13103, 2018
252018
ADAMTS proteases and the tumor immune microenvironment: Lessons from substrates and pathologies
S Redondo-García, C Peris-Torres, R Caracuel-Peramos, ...
Matrix Biology Plus 9, 100054, 2021
132021
ADAMTS1 supports endothelial plasticity of glioblastoma cells with relevance for glioma progression
O Serrano-Garrido, C Peris-Torres, S Redondo-García, HG Asenjo, ...
Biomolecules 11 (1), 44, 2021
82021
Human leukocyte immunoglobulin-like receptors in health and disease
S Redondo-García, C Barritt, C Papagregoriou, M Yeboah, B Frendeus, ...
Frontiers in Immunology 14, 1282874, 2023
22023
Evaluation of Tumor Vasculature Using a Syngeneic Tumor Model in Wild-Type and Genetically Modified Mice
FJ Rodríguez-Baena, S Redondo-García, MC Plaza-Calonge, ...
Proteases and Cancer: Methods and Protocols, 179-192, 2018
12018
Characterization of syngeneic tumor models and their microenvironment for immunotherapeutic approaches
M Carretta, ML Thorseth, D Agardy, S Redondo Garcia, AMH Larsen, ...
JOURNAL FOR IMMUNOTHERAPY OF CANCER 7, 2019
2019
The system can't perform the operation now. Try again later.
Articles 1–6